Search Results For ''

  • Encouraging results from Recce Pharmaceuticals in fight against drug resistant bacteria

    As the world prepares for a myriad of drug-resistant bacteria following decades of over-prescribing and improper use of antibiotics, Recce Pharmaceuticals (ASX: RCE) has reported encouraging clinical results in response to multi drug resistant bacterial sinusitis infection. Following on from promising results observed in animal studies, a 59-year-old male was treated with the compound R327

    Read More
    Public
  • No international students, no problem – iCollege records record revenue

    Despite the travel restrictions that have limited international student enrollments in Australia, domestic students have used the opportunity to hone their skill sets with education provider iCollege (ASX: ICT) recording record revenue for the March quarter.  Revenue for the quarter was up 52% to $4.55 million compared to the previous corresponding quarter ($2.99m) when the

    Read More
    Public
  • Crowd Media showcases newest AI as example of disruption to eCommerce

    Online shopping experiences will soon be very different to the current one-dimensional standard following the launch of artificial intelligence company Crowd Media’s (ASX: CM8) latest talking head which was produced entirely by digital media and powered by AI.  The talking head named ‘Digital Dom’ is a digital avatar of Crowd’s co-founder and Director Domenic Carosa

    Read More
    Public
  • Investor loads up on aspirin in response to COVID vaccine side effects

    Amid news of the COVID-19 vaccine leading to blood clotting as a side effect among recipients, investor Hugh Honey has identified an investment opportunity whereby he has emptied the shelves of supermarkets and pharmacies across the country, hoarding all the aspirin he can get his hands on.  Honey, a long time aspirin user, drew upon

    Read More
    Public
  • Australia’s China Hustle

    Several large Chinese operations have listed on the ASX across the past five years, usually with impressive financials and promises of strong, consistent, future growth. These companies have always been attractively priced and always seemed to report extremely well. What was the problem? Well, put simply, some of these companies may not exist at all,

    Read More
    Public
  • Here’s cheers: the craft beer market offers plenty of upside to the discerning operators

    Investors thirsting for an ASX beer exposure have been left largely unsated since Fosters/Carlton United Breweries and Lion Nathan were subsumed by foreign buyers a few years back. Coca Cola Amatil (CCL) has long held beer and spirits ambitions that have never quite come to fruition, but in any event the bottler looks headed to

    Read More
    Public